Delivery Order SPE2DB22D1017-SPE2DB25FYRLE
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,562.51 on September 18, 2025, for the supply of Emgality 300 mg (100 mg x3 syringe/mL) under a Defense Logistics Agency Medical Supply Chain contract. The award is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 19, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single task against...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,547.00 by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Emgality 300 mg (100 mg x 3 syringe/ml). This competitively awarded, firm fixed-price delivery order is non-set-aside and is scheduled for completion by August 26, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,088.94 to AmerisourceBergen Drug Corp for the supply of Emgality 300 mg (100 mg x 3 syringes). This firm fixed-price, non-set-aside delivery order was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025. The product will be delivered to Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution center. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,729.00 by the Defense Logistics Agency on August 26, 2025, for the supply of Emgality 120 mg/ml pen injections. This is a firm fixed price, non-set-aside contract with a completion date of August 27, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $798.51 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply Emgality 120 mg/ml syringes. The single day contract has a period of performance from July 13, 2023 through July 14, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,729.00 by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Emgality 120 mg/mL pen injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the pharmaceutical product Emgality 120 mg/mL pen on May 20, 2025, with a ceiling value of $1,037.40. This firm fixed-price contract is non-competitive and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,547.00 to AmerisourceBergen Drug Corp for the supply of Emgality 300 mg (100 mg x3 syringe/mL) on November 10, 2025, with an ultimate completion date of November 12, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, the headquarters location of the prime contractor....
- The Defense Logistics Agency awarded a delivery order valued at $3,309.37 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen injectors. This firm fixed price, competitively awarded contract was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has received a delivery order from the Defense Logistics Agency (DLA) valued at $7,827.19 for Emgality 120 mg/ml pen injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 25, 2025, and represents a non-set-aside contract. The product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...